Condition
Cholesterol Ester Storage Disease
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Recruiting1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01633489Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT02383641Withdrawn
Biomarker for Wolman Disease (BioWolman)
NCT01884220Completed
Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
NCT01716728Not ApplicableUnknown
Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
NCT01791452Unknown
Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study
Showing all 5 trials